Skip to main content
MedPathMedPath Home
Clinical Trials/NCT05118022
NCT05118022
Completed
Not Applicable

Artificial Intelligence Identified Dyskalemia Using Electrocardiogram (AIDE) Prompts Immediate Treatment

National Defense Medical Center, Taiwan1 site in 1 country14,989 target enrollmentJanuary 1, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHyperkalemiaHypokalemia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hyperkalemia
Sponsor
National Defense Medical Center, Taiwan
Enrollment
14989
Locations
1
Primary Endpoint
Cumulative proportion of hyperkalemia treatment
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of potassium abnormalities.

Registry
clinicaltrials.gov
Start Date
January 1, 2022
End Date
February 28, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
National Defense Medical Center, Taiwan
Responsible Party
Principal Investigator
Principal Investigator

Chin Lin

Associate Professor

National Defense Medical Center, Taiwan

Eligibility Criteria

Inclusion Criteria

  • •Patients in emergency department.
  • •Patients recieved at least 1 ECG examination.

Exclusion Criteria

  • •Patients recieved dyskalemia-related treatment before ECG examination.
  • •The patients recieved ECG at the period of inactive AI-ECG system.

Outcomes

Primary Outcomes

Cumulative proportion of hyperkalemia treatment

Time Frame: Within 3 hours

Calcium supplement, insulin, potassium binding resin, β2-agonist, loop diuretics, sodium bicarbonate, and hemodialysis.

Cumulative proportion of hypokalemia treatment

Time Frame: Within 3 hours

Intravenous potassium chloride, oral potassium gluconate, and oral potassium chloride

Secondary Outcomes

  • Cardiac arrest (sudden death)(Within 3 days)
  • Cumulative proportion of All-cause mortality(Within 365 days)
  • Cumulative proportion of electric shock(Within 6 hours)
  • Cumulative proportion of CPR event(Within 6 hours)
  • Cumulative proportion of Discharge(Within 14 days)
  • Cumulative proportion of Treatment-induced hypokalemia event(Within 24 hours)
  • Cumulative proportion of Treatment-induced hyperkalemia event(Within 24 hours)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Artificial Intelligence-assisted Diagnosis and Prognostication in Low Ejection Fraction Using ElectrocardiogramsLeft Ventricular Systolic Dysfunction (Disorder)
NCT05117970National Defense Medical Center, Taiwan13,631
Completed
Not Applicable
Applying an Artificial Intelligence-Enabled Electrocardiographic System for Reducing MortalityCardiovascular DiseasesIntensity CareMorality
NCT05118035National Defense Medical Center, Taiwan15,965
Completed
Not Applicable
CARDIOLOGIST Trial: Artificial Intelligence Enabled Electrocardiogram for Atrial Fibrillation DetectionAtrial Fibrillation New Onset
NCT05127460National Defense Medical Center, Taiwan25,732
Completed
Not Applicable
ECG AI-Guided Screening for Low Ejection FractionAsymptomatic Left Ventricular Systolic Dysfunction (Disorder)Heart Failure
NCT04000087Mayo Clinic358
Completed
Not Applicable
Artificial Intelligence Based Rapid Identification of ST-elevation Myocardial Infarction Using Electrocardiogram (ARISE)Myocardial Infarction, Acute
NCT05118009National Defense Medical Center, Taiwan43,176